• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Reply to "Highly Efficacious Novel Vaccine, Humoral Immunity, and Ocular Herpes Simplex Virus 1: Reality or Myth?".

作者信息

Royer Derek J, Carr Daniel J J

机构信息

Department of Ophthalmology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.

Department of Ophthalmology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA

出版信息

J Virol. 2017 Nov 14;91(23). doi: 10.1128/JVI.01464-17. Print 2017 Dec 1.

DOI:10.1128/JVI.01464-17
PMID:29138328
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5686737/
Abstract
摘要

相似文献

1
Reply to "Highly Efficacious Novel Vaccine, Humoral Immunity, and Ocular Herpes Simplex Virus 1: Reality or Myth?".对《高效新型疫苗、体液免疫与单纯疱疹病毒1型眼部感染：现实还是神话？》的回复
J Virol. 2017 Nov 14;91(23). doi: 10.1128/JVI.01464-17. Print 2017 Dec 1.
2
Highly Efficacious Novel Vaccine, Humoral Immunity, and Ocular Herpes Simplex Virus 1: Reality or Myth?高效新型疫苗、体液免疫与单纯疱疹病毒1型眼部感染：现实还是神话？
J Virol. 2017 Nov 14;91(23). doi: 10.1128/JVI.01421-17. Print 2017 Dec 1.
3
Modelling efforts needed to advance herpes simplex virus (HSV) vaccine development: Key findings from the World Health Organization Consultation on HSV Vaccine Impact Modelling.推进单纯疱疹病毒（HSV）疫苗开发所需的建模工作：世界卫生组织 HSV 疫苗影响建模咨询会的主要发现。
Vaccine. 2019 Nov 28;37(50):7336-7345. doi: 10.1016/j.vaccine.2017.03.074. Epub 2017 Jun 21.
4
A Highly Efficacious Herpes Simplex Virus 1 Vaccine Blocks Viral Pathogenesis and Prevents Corneal Immunopathology via Humoral Immunity.一种高效的单纯疱疹病毒1型疫苗可通过体液免疫阻断病毒发病机制并预防角膜免疫病理。
J Virol. 2016 May 12;90(11):5514-5529. doi: 10.1128/JVI.00517-16. Print 2016 Jun 1.
5
Correlation between herpes simplex virus neutralizing antibody titers determined by ELVIS cell and traditional plaque reduction assays.ELVIS 细胞法和传统蚀斑减少试验法检测单纯疱疹病毒中和抗体效价的相关性。
PLoS One. 2019 Apr 4;14(4):e0214467. doi: 10.1371/journal.pone.0214467. eCollection 2019.
6
Potential prophylactic and therapeutic vaccines for HSV infections.针对单纯疱疹病毒感染的潜在预防性和治疗性疫苗。
Curr Pharm Des. 2007;13(19):1965-73. doi: 10.2174/138161207781039760.
7
New concepts in herpes simplex virus vaccine development: notes from the battlefield.单纯疱疹病毒疫苗研发的新概念：战场笔记
Expert Rev Vaccines. 2009 Aug;8(8):1023-35. doi: 10.1586/erv.09.60.
8
Immunobiology of herpes simplex virus (HSV) infections.单纯疱疹病毒（HSV）感染的免疫生物学
Herpes. 2001 Mar;8 Suppl 1:1A.
9
T cell immunity to herpes simplex viruses in seronegative subjects: silent infection or acquired immunity?血清阴性受试者对单纯疱疹病毒的T细胞免疫：潜伏感染还是获得性免疫？
J Immunol. 2003 Apr 15;170(8):4380-8. doi: 10.4049/jimmunol.170.8.4380.
10
Prospects and perspectives for development of a vaccine against herpes simplex virus infections.针对单纯疱疹病毒感染开发疫苗的前景与展望。
Expert Rev Vaccines. 2014 Nov;13(11):1349-60. doi: 10.1586/14760584.2014.932694. Epub 2014 Jul 31.

本文引用的文献

1
The Neonatal Fc Receptor and Complement Fixation Facilitate Prophylactic Vaccine-Mediated Humoral Protection against Viral Infection in the Ocular Mucosa.新生儿Fc受体与补体固定作用促进预防性疫苗介导的眼黏膜体液免疫以抵御病毒感染。
J Immunol. 2017 Sep 1;199(5):1898-1911. doi: 10.4049/jimmunol.1700316. Epub 2017 Jul 31.
2
Original antigenic sin: A comprehensive review.原始抗原性失误：全面回顾。
J Autoimmun. 2017 Sep;83:12-21. doi: 10.1016/j.jaut.2017.04.008. Epub 2017 May 5.
3
Impact of Type I Interferon on the Safety and Immunogenicity of an Experimental Live-Attenuated Herpes Simplex Virus 1 Vaccine in Mice.I型干扰素对实验性减毒活单纯疱疹病毒1型疫苗在小鼠体内安全性和免疫原性的影响。
J Virol. 2017 Mar 13;91(7). doi: 10.1128/JVI.02342-16. Print 2017 Apr 1.
4
Rigorous Science: a How-To Guide.严谨科学：操作指南。
mBio. 2016 Nov 8;7(6):e01902-16. doi: 10.1128/mBio.01902-16.
5
Sex differences in immune responses.性别差异与免疫反应。
Nat Rev Immunol. 2016 Oct;16(10):626-38. doi: 10.1038/nri.2016.90. Epub 2016 Aug 22.
6
A Highly Efficacious Herpes Simplex Virus 1 Vaccine Blocks Viral Pathogenesis and Prevents Corneal Immunopathology via Humoral Immunity.一种高效的单纯疱疹病毒1型疫苗可通过体液免疫阻断病毒发病机制并预防角膜免疫病理。
J Virol. 2016 May 12;90(11):5514-5529. doi: 10.1128/JVI.00517-16. Print 2016 Jun 1.
7
Beyond antigens and adjuvants: formulating future vaccines.超越抗原和佐剂：未来疫苗的配方设计
J Clin Invest. 2016 Mar 1;126(3):799-808. doi: 10.1172/JCI81083.
8
The Current State of Vaccine Development for Ocular HSV-1 Infection.眼部单纯疱疹病毒1型感染疫苗研发的现状
Expert Rev Ophthalmol. 2015 Apr 1;10(2):113-126. doi: 10.1586/17469899.2015.1004315.
9
Herpes simplex type 2 virus deleted in glycoprotein D protects against vaginal, skin and neural disease.糖蛋白D缺失的2型单纯疱疹病毒可预防阴道、皮肤和神经疾病。
Elife. 2015 Mar 10;4:e06054. doi: 10.7554/eLife.06054.
10
Antigenic breadth: a missing ingredient in HSV-2 subunit vaccines?抗原广谱性：HSV-2 亚单位疫苗的缺失成分？
Expert Rev Vaccines. 2014 Jun;13(6):691-710. doi: 10.1586/14760584.2014.910121.